Literature DB >> 21168504

Metastasis suppressors and the tumor microenvironment.

Leah M Cook1, Douglas R Hurst, Danny R Welch.   

Abstract

The most lethal and debilitating attribute of cancer cells is their ability to metastasize. Throughout the process of metastasis, tumor cells interact with other tumor cells, host cells and a variety of molecules. Tumor cells are also faced with a number of insults, such as hemodynamic sheer pressure and immune selection. This brief review explores how metastasis suppressor proteins regulate interactions between tumor cells and the microenvironments in which tumor cells find themselves.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168504      PMCID: PMC3053584          DOI: 10.1016/j.semcancer.2010.12.005

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  134 in total

Review 1.  Adherens junctions: from molecules to morphogenesis.

Authors:  Tony J C Harris; Ulrich Tepass
Journal:  Nat Rev Mol Cell Biol       Date:  2010-07       Impact factor: 94.444

2.  Loss of DCC expression and glioma progression.

Authors:  M Reyes-Mugica; K Rieger-Christ; H Ohgaki; B C Ekstrand; M Helie; G Kleinman; A Yahanda; E R Fearon; P Kleihues; M A Reale
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

3.  KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.

Authors:  Fu-Shing Liu; Jin-Tang Dong; Jung-Ta Chen; Yeun-Ting Hsieh; Esther Shih-Chu Ho; Man-Jung Hung; Chien-Hsing Lu; Li-Ching Chiou
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

4.  Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis.

Authors:  S Miyake; K Nagai; K Yoshino; M Oto; M Endo; Y Yuasa
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

5.  Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.

Authors:  Muzaffer Cicek; Ryuichi Fukuyama; Danny R Welch; Nywana Sizemore; Graham Casey
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

6.  Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.

Authors:  Nicholas Trakul; Raymond E Menard; George R Schade; Zhijian Qian; Marsha Rich Rosner
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

7.  The Drg-1 gene suppresses tumor metastasis in prostate cancer.

Authors:  Sucharita Bandyopadhyay; Sudha K Pai; Steven C Gross; Shigeru Hirota; Sadahiro Hosobe; Kunio Miura; Ken Saito; Therese Commes; Sunao Hayashi; Misako Watabe; Kounosuke Watabe
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

8.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

Authors:  Steve Goodison; Jing Yuan; Derek Sloan; Ryung Kim; Cheng Li; Nicholas C Popescu; Virginia Urquidi
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

9.  KiSS-1, a novel human malignant melanoma metastasis-suppressor gene.

Authors:  J H Lee; M E Miele; D J Hicks; K K Phillips; J M Trent; B E Weissman; D R Welch
Journal:  J Natl Cancer Inst       Date:  1996-12-04       Impact factor: 13.506

Review 10.  Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation.

Authors:  Garth L Nicolson; Akihiro Nawa; Yasushi Toh; Shigeki Taniguchi; Katsuhiko Nishimori; Amr Moustafa
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more
  26 in total

Review 1.  Targeted therapies for adrenocortical carcinoma: IGF and beyond.

Authors:  Michael J Demeure; Kimberly J Bussey; Lawrence S Kirschner
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

Review 2.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.

Authors:  Xing Ai; Zhuo-Min Jia; Juan Wang; Gui-Ping DI; X U Zhang; Fengling Sun; Tong Zang; Xiumei Liao
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

4.  Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.

Authors:  Raúl Catena; Nandita Bhattacharya; Tina El Rayes; Suming Wang; Hyejin Choi; Dingcheng Gao; Seongho Ryu; Natasha Joshi; Diane Bielenberg; Sharrell B Lee; Svein A Haukaas; Karsten Gravdal; Ole J Halvorsen; Lars A Akslen; Randolph S Watnick; Vivek Mittal
Journal:  Cancer Discov       Date:  2013-04-30       Impact factor: 39.397

Review 5.  Unravelling the complexity of metastasis - molecular understanding and targeted therapies.

Authors:  Nilay Sethi; Yibin Kang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

6.  CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.

Authors:  Hangyi H Yan; Jian Jiang; Yanli Pang; B R Achyut; Michael Lizardo; Xinhua Liang; Kent Hunter; Chand Khanna; Christine Hollander; Li Yang
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

7.  Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer.

Authors:  Michael J Flister; Shirng-Wern Tsaih; Alexander Stoddard; Cody Plasterer; Jaidip Jagtap; Abdul K Parchur; Gayatri Sharma; Anthony R Prisco; Angela Lemke; Dana Murphy; Mona Al-Gizawiy; Michael Straza; Sophia Ran; Aron M Geurts; Melinda R Dwinell; Andrew S Greene; Carmen Bergom; Peter S LaViolette; Amit Joshi
Journal:  Breast Cancer Res Treat       Date:  2017-05-31       Impact factor: 4.872

8.  Cancer Metastases: So Close and So Far.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  J Natl Cancer Inst       Date:  2015-08-17       Impact factor: 13.506

Review 9.  Miniaturized pre-clinical cancer models as research and diagnostic tools.

Authors:  Maria Håkanson; Edna Cukierman; Mirren Charnley
Journal:  Adv Drug Deliv Rev       Date:  2013-12-01       Impact factor: 15.470

10.  KiSS1/GPR54 and estrogen-related gene expression profiles in primary breast cancer.

Authors:  Katarzyna Jarząbek; Leszek Kozłowski; Robert Milewski; Sławomir Wołczyński
Journal:  Oncol Lett       Date:  2012-01-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.